Chamomile Tea and Supplements: Safety and Drug Interactions

1. German vs. Roman Chamomile: Two Different Plants

The first thing worth clarifying is that “chamomile” actually refers to two distinct species that are often conflated in popular usage. German chamomile (Matricaria chamomilla, also classified as Matricaria recutita) is the species most commonly used in teas and clinical research. It is an annual plant native to Europe and Western Asia with a mild, apple-like aroma and small white daisy-shaped flowers. When you buy chamomile tea at a grocery store, this is almost certainly what you are getting.

Roman chamomile (Chamaemelum nobile, formerly Anthemis nobilis) is a perennial plant more commonly used in essential oils and aromatherapy. It has a somewhat more bitter flavor profile and a different chemical composition, with higher concentrations of certain esters. Roman chamomile is more often encountered in topical preparations and essential oil blends than in drinkable teas.

This distinction matters because most of the clinical research on chamomile's internal use, including the anxiety and sleep studies discussed below, has been conducted with German chamomile. When we talk about chamomile tea interactions, we are primarily talking about Matricaria chamomilla. The two species share some active compounds, but they are not identical, and safety data from one does not automatically transfer to the other.

2. Active Compounds: Apigenin, Bisabolol, and Chamazulene

Chamomile contains over 120 identified chemical constituents, but three are particularly relevant to understanding both its therapeutic effects and its interaction potential.

Apigenin

Apigenin is a flavonoid that binds to benzodiazepine receptors on the GABA-A receptor complex. This is the same receptor system targeted by drugs like diazepam and alprazolam, though apigenin binds with much lower affinity. This binding is thought to be the primary mechanism behind chamomile's calming and mildly sedative effects. Apigenin has also shown anti-inflammatory activity in laboratory studies and is a known inhibitor of CYP3A4, a liver enzyme responsible for metabolizing a large percentage of pharmaceutical drugs. This CYP inhibition is where several of chamomile's drug interaction concerns originate.

Alpha-Bisabolol

Alpha-bisabolol is a sesquiterpene alcohol with well-documented anti-inflammatory, anti-irritant, and antimicrobial properties. It is one of the reasons chamomile has traditionally been used for digestive complaints and skin irritation. Bisabolol appears to work partly through inhibition of pro-inflammatory pathways, including cyclooxygenase-2 (COX-2). From an interaction standpoint, bisabolol is less concerning than apigenin, but its anti-inflammatory activity could theoretically add to the effects of other anti-inflammatory agents.

Chamazulene

Chamazulene is not actually present in the raw plant material. It forms during steam distillation of chamomile flowers, which is why chamomile essential oil has that distinctive deep blue color. Chamazulene has potent antioxidant and anti-inflammatory properties in laboratory settings, but because it is primarily found in essential oil rather than tea, its relevance to typical chamomile tea consumption is limited. It becomes more relevant when discussing concentrated chamomile essential oil products.

3. What the Research Shows for Anxiety

The most compelling clinical evidence for chamomile involves its effects on anxiety, and two studies in particular stand out for their methodological quality.

The Amsterdam 2009 GAD Trial

In 2009, Jay Amsterdam and colleagues at the University of Pennsylvania published the first randomized, double-blind, placebo-controlled trial of chamomile for generalized anxiety disorder (GAD) in the Journal of Clinical Psychopharmacology. Fifty-seven participants with mild to moderate GAD received either 220 mg of a standardized Matricaria chamomilla extract (standardized to 1.2% apigenin) or placebo for 8 weeks. The chamomile group showed a statistically significant reduction in Hamilton Anxiety Rating Scale (HAM-A) scores compared to placebo. The effect size was modest but meaningful, and side effects were minimal.

The Keefe 2016 Long-Term Follow-Up

Building on the 2009 findings, Keefe and colleagues (including Amsterdam) published a longer-term study in Phytomedicine in 2016. This trial enrolled 179 participants with moderate to severe GAD for an initial 12-week open-label phase with chamomile extract (1,500 mg/day, a substantially higher dose than the 2009 trial). Responders were then randomized to either continue chamomile or switch to placebo for an additional 26 weeks. The results showed that chamomile was associated with a significant reduction in relapse rates compared to placebo during the continuation phase. Participants who stayed on chamomile also maintained lower anxiety scores and reported meaningful improvements in body weight and blood pressure, suggesting possible secondary benefits.

These two studies are important because they move chamomile beyond the realm of traditional folk remedy and into the territory of evidence-based, if modest, anxiolytic therapy. They do not suggest that chamomile should replace standard treatments for severe anxiety, but they do support the idea that it has genuine pharmacological activity beyond placebo.

4. Blood Thinner Interactions

Chamomile contains natural coumarin compounds. Coumarins are a broad class of chemicals found in many plants, and some of them have anticoagulant properties. Warfarin (Coumadin) itself is derived from a coumarin compound, so there is a clear pharmacological basis for concern about additive effects.

Case Reports

Several case reports in the medical literature have documented elevated INR (international normalized ratio, a measure of blood clotting time) in patients taking warfarin who were also consuming chamomile products. A frequently cited case published in Pharmacotherapy (2006) described a 70-year-old woman on stable warfarin therapy whose INR rose to dangerously elevated levels after she began drinking chamomile tea several times daily and using a chamomile-based skin lotion. Her INR normalized after discontinuing the chamomile products.

Another report in the Canadian Medical Association Journal described a similar pattern of INR elevation in a warfarin patient who had increased chamomile tea consumption. While case reports cannot establish causation with certainty (other factors like dietary changes or illness could contribute), the pattern across multiple independent reports, combined with the known coumarin content, provides reasonable grounds for caution.

Tea vs. Concentrate: An Important Distinction

Context matters enormously here. The coumarin content in a cup of chamomile tea is relatively low. Casual tea consumption (one to two cups per day) is unlikely to produce a clinically significant anticoagulant effect on its own in most people. The concern escalates with concentrated extracts, high-dose capsules, and heavy daily tea consumption (multiple cups per day over extended periods). The case reports involving elevated INR generally describe patients who were drinking chamomile tea frequently and in substantial quantities, not people having an occasional cup.

If you take warfarin, other vitamin K antagonists, or direct oral anticoagulants (DOACs like apixaban, rivarelbane, or dabigatran), it is worth being aware of this interaction. An occasional cup of chamomile tea is unlikely to cause problems, but regular heavy consumption or supplementation with concentrated chamomile extract warrants a conversation with your prescriber, especially since warfarin dosing is already sensitive to dietary and herbal factors.

5. Sedative Medication Interactions

Because apigenin binds to the benzodiazepine site on GABA-A receptors, chamomile has the potential to produce additive central nervous system (CNS) depression when combined with other substances that enhance GABAergic signaling. The practical effect is increased drowsiness, slowed reaction times, and in more significant cases, impaired coordination and cognition.

Benzodiazepines

Benzodiazepines like diazepam, lorazepam, alprazolam, and clonazepam bind at the same GABA-A receptor complex that apigenin targets, though at a different site and with dramatically greater affinity. The theoretical concern is that chamomile could amplify the sedative effects of these medications. While published case reports specifically documenting this combination are limited, the pharmacological reasoning is sound, and most clinical references flag it as a potential concern.

Z-Drugs

The “Z-drugs” used for insomnia (zolpidem, zopiclone, zaleplon) also act on GABA-A receptors, specifically at the alpha-1 subunit. The same additive sedation concern applies. If you are prescribed a Z-drug for sleep and also drink chamomile tea before bed, the combined sedative effect could be greater than either alone, which may sound desirable but can cross into excessive drowsiness and impaired next-morning alertness.

Alcohol

Alcohol enhances GABA-A receptor function and independently depresses central nervous system activity. Combining alcohol with chamomile creates an additive sedation scenario. For most people, having chamomile tea on an evening when they have also had a glass of wine is unlikely to cause a problem. But it is worth being aware that the combination can potentiate drowsiness, and heavy alcohol consumption alongside regular chamomile supplementation (especially concentrated extracts) is a different matter entirely.

6. Diabetes Medication Interactions

A number of animal studies and a small number of human studies have found that chamomile may have blood sugar lowering effects. A 2014 study published in the Journal of Endocrinological Investigation found that chamomile tea consumed three times daily for 8 weeks significantly reduced HbA1c, serum insulin, and insulin resistance scores (HOMA-IR) in patients with type 2 diabetes, compared to a control group that drank water.

While these glucose-lowering effects may be beneficial for some individuals, they raise a concern for people taking insulin, sulfonylureas (glipizide, glyburide), or other hypoglycemic agents. The combination could theoretically lead to additive blood sugar lowering, increasing the risk of hypoglycemia. This is particularly relevant for people on tight glycemic control or those prone to hypoglycemic episodes. The clinical significance of this interaction at typical tea-drinking levels is probably modest, but it becomes more relevant with concentrated chamomile supplements taken consistently alongside diabetes medication.

7. CYP Enzyme Interactions

Apigenin is a known inhibitor of CYP3A4, and this is potentially the most pharmacologically broad of chamomile's drug interactions. CYP3A4 is the single most important drug-metabolizing enzyme in the human liver, responsible for processing roughly 50% of all pharmaceutical drugs. When CYP3A4 is inhibited, drugs that rely on it for metabolism can accumulate to higher-than-intended blood levels, increasing the risk of side effects.

An in vitro study published in Life Sciences (2004) demonstrated that apigenin inhibits CYP3A4 activity in a dose-dependent manner. However, the concentrations used in laboratory studies are often higher than what would be achieved through normal dietary chamomile consumption. The question, as with many herbal interactions, is whether the inhibition seen in a test tube translates to clinically meaningful effects in a living person drinking tea.

At typical tea consumption levels, the CYP3A4 inhibition from chamomile is likely to be mild. But for people taking medications with narrow therapeutic windows that are CYP3A4 substrates (including cyclosporine, tacrolimus, certain statins like simvastatin and atorvastatin, and some calcium channel blockers), even a modest shift in drug metabolism can matter. High-dose chamomile supplements are more likely to produce meaningful CYP3A4 inhibition than a cup of tea.

8. Allergy Concerns: The Ragweed Connection

This is the chamomile interaction that people tend to underestimate, and it has nothing to do with drug metabolism. Chamomile belongs to the Asteraceae family (also called Compositae), which includes ragweed, chrysanthemums, daisies, marigolds, and sunflowers. People with existing allergies to any of these plants can experience cross-reactive allergic responsesto chamomile.

These reactions range from mild (skin rash, itching, nasal congestion) to severe. There are documented cases of anaphylaxis triggered by chamomile in individuals with ragweed allergy. A case report in the Journal of Allergy and Clinical Immunology described a patient who developed full anaphylaxis after drinking chamomile tea, with subsequent allergy testing confirming cross-reactivity with ragweed pollen proteins. While anaphylaxis from chamomile is rare in absolute terms, it is a genuine risk for sensitized individuals.

If you have a known allergy to ragweed, chrysanthemums, daisies, or other Asteraceae plants, approach chamomile with real caution. This applies to all forms: tea, extracts, essential oil, and topical products. For people without these allergies, chamomile allergy is uncommon but not impossible, and anyone experiencing itching, swelling, or difficulty breathing after consuming chamomile should seek medical attention promptly.

9. Pregnancy Considerations

Chamomile tea is one of the most common herbal teas consumed during pregnancy, often used to manage nausea, anxiety, and sleep difficulties. However, the safety data for chamomile in pregnancy is limited, and there are some reasons for caution.

Animal studies have shown that chamomile extracts can have uterotonic effects, meaning they may stimulate uterine contractions. Whether this translates to a meaningful risk at human tea-drinking doses is unclear, but it is the basis for the recommendation found in many clinical references that pregnant individuals should avoid concentrated chamomile supplements and use chamomile tea only in moderation, if at all.

A 2019 observational study in BMC Complementary Medicine and Therapies found no association between moderate chamomile tea consumption and adverse pregnancy outcomes, which is somewhat reassuring. But the study design could not rule out risk, and most professional guidelines (including those from the European Medicines Agency) note that safety during pregnancy has not been established. Occasional, light chamomile tea consumption is generally considered low-risk, but daily use of high-dose chamomile supplements during pregnancy is not well supported by the available evidence.

10. Tea vs. Extract vs. Essential Oil

One of the most important and most frequently overlooked aspects of chamomile safety is that different preparations deliver vastly different concentrations of active compounds, and they have very different safety profiles as a result.

Chamomile Tea

A standard cup of chamomile tea, brewed with 1 to 2 grams of dried flowers in hot water for 5 to 10 minutes, delivers a relatively modest dose of apigenin and other active compounds. The hot water extraction process is not particularly efficient at pulling out all of the pharmacologically active constituents. For most healthy adults, one to three cups of chamomile tea per day is considered safe by essentially all major herbal medicine authorities, including the German Commission E and the European Medicines Agency.

Standardized Extracts

Chamomile extract capsules and tinctures contain much higher concentrations of active compounds than tea. The clinical trials discussed above used standardized extracts delivering specific amounts of apigenin (e.g., 1.2% apigenin in the Amsterdam trial). At these doses, the pharmacological activity is substantially greater than what a cup of tea provides, and so are the interaction risks. Most of the drug interaction concerns discussed in this article are more relevant to extract-level doses than to casual tea consumption.

Essential Oil

Chamomile essential oil is the most concentrated form and has a fundamentally different safety profile. Essential oils should never be ingested without professional guidance. They are primarily used in aromatherapy (inhaled or diffused) or diluted for topical application. The essential oil contains high concentrations of chamazulene and bisabolol but also compounds that can be irritating or toxic if swallowed undiluted. Topical chamomile essential oil can also trigger contact dermatitis, particularly in individuals with Asteraceae allergies.

11. The Bedtime Tea Question

This brings us to what might be the most commonly asked question about chamomile: does the nightly cup of chamomile tea actually help you sleep, or is it mostly ritual and placebo?

The honest answer is that it is probably both, and that is not a dismissal. The pharmacological evidence shows that apigenin does bind to GABA receptors and does have mild sedative properties in laboratory and clinical settings. A 2017 randomized controlled trial in Complementary Therapies in Medicine found that elderly participants who took chamomile extract capsules (200 mg, twice daily) for 28 days showed statistically significant improvements in sleep quality compared to placebo, as measured by the Pittsburgh Sleep Quality Index.

But a cup of tea is also a ritual. The act of preparing a warm drink, sitting quietly, slowing down, and engaging in a comforting sensory experience (warmth, aroma, taste) has real value for the nervous system, independent of any specific chemical compound. The warm liquid itself promotes vasodilation and a subtle drop in core body temperature afterward, which is a physiological signal for sleepiness. The ritual signals to your brain that the day is winding down.

Separating the pharmacological effect of chamomile from the contextual effects of the bedtime tea ritual is genuinely difficult, and trying to do so may actually miss the point. If your nightly chamomile tea helps you feel calmer and sleep better, it is working through some combination of real chemistry and meaningful ritual. Both of those are valid. The key is simply to be aware of the interaction considerations discussed above, especially if you take blood thinners, sedative medications, or diabetes drugs, or if you have Asteraceae family allergies.

For most people, a cup or two of chamomile tea in the evening is a perfectly safe and potentially helpful part of a healthy bedtime routine. The concerns in this article apply primarily to concentrated supplements, heavy consumption, and specific medication combinations. A thoughtful approach that accounts for your own health situation is all that is needed.